The Technical Analyst
Loncar Cancer [CNCR]
Exchange: NASDAQ
Loncar Cancer Price, Forecast, Insider, Ratings, Fundamentals & Signals
3.15% $14.39
America/New_York / 26 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 29.57 mill |
| EPS: | 0 |
| P/E: | 0 |
| Earnings Date: | N/A |
| SharesOutstanding: | 2.05 mill |
| Avg Daily Volume: | 0.0385 mill |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 14.70 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 17.27 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 13.95 - 14.91 ( +/- 3.31%) |
| ATR Model: 14 days |
Forecast:
16:00 - $14.43
Live Trading Signals (every 1 min)
Forecast
1: 15:36 - $14.46
Forecast 2: 16:00 - $14.43
Forecast 3: 16:00 - $14.43
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $14.39 (3.15% ) |
| Volume | 0.0032 mill |
| Avg. Vol. | 0.0385 mill |
| % of Avg. Vol | 8.36 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CNCR
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
CNCR
The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The adviser attempts to invest all, or substantially all, of its assets in the component securities and ADRs that make up the index. At least 80% of its total assets will be invested in the component securities of the index. The fund is non-diversified.
Latest News
2024-03-27 12:10:16 - Zacks Investment Research
5 Market-Beating Sector ETFs of Q1
Wall Street is set to wrap up the first quarter with strong gains. The gains were broad-based and well spread out across various segments.
2024-03-04 09:01:07 - Zacks Investment Research
Top & Flop ETF Areas of Wall Street's Best February in Decade
Wall Street surged to close out February with the S&P 500 and Nasdaq Composite notching their best February since 2015.
2024-02-29 13:01:27 - Zacks Investment Research
5 Best-Performing Sector ETFs of February
The gains were broad-based and well spread out across various segments. We have highlighted some of the top performers in the ETF space from different sectors of the market.
2024-02-12 12:06:23 - Zacks Investment Research
5 Sector ETFs Beating the Market Halfway Through Q1
A combination of factors, including a solid earnings season, a resilient economy and a technology surge, powered the rally, resulting in a gain of about 5% for the S&P 500 Index this year.
2024-01-24 14:58:49 - ETF Trends
Range Debuts 4 Energy-Related ETFs
Range ETFs expanded its lineup on Wednesday to include four energy-related ETFs. They cover the coal, natural gas, oil services, and nuclear industries.
2023-10-30 15:02:03 - Zacks Investment Research
5 ETF Areas That Spooked Investors in October
After a downbeat September, October too remained volatile for Wall Street due to higher rates.
2023-10-27 15:13:45 - ETF Trends
This Week in ETFs: 4 New Single-Stock Funds Debut
While the ETF industry didn't see over-the-top activity, the past week was fairly busy, with 11 new ETFs making their debut and six ETFs shutting down. Among the launches were two covered call funds from Goldman Sachs and a new fund from YieldMax that offers a covered call strategy tied to the stock of Moderna.
2023-06-28 10:36:32 - Zacks Investment Research
Best & Worst Sector ETFs of First-Half 2023
2023-06-26 16:37:38 - ETF Trends
Last Week in ETFs: 15 Launches, Closures Continue Rapid Pace
It was a busy week for ETF launches and closures. A total of 15 ETFs launched during the week shortened by the Juneteenth holiday, defying the typically slow launch count for weeks surrounding three-day weekends.
2023-04-24 17:48:40 - ETF Trends
ALPS' Biotech ETF SBIO Week's Top Performer
In a somewhat surprising turn, biotech and life sciences-focused ETFs were the driving themes in the last week's top-performing ETFs, with the ALPS Medical Breakthroughs ETF (SBIO) leading the way with a 10% return.